Percentage change per year of retinal layers are summarized in Table 5 and in Supplementary Table 5. In addition, absolute thickness changes per year of retinal layers are summarized in Supplementary Table 6, as well as in Fig. 2B. There were no differences between rates of retinal layer atrophy in African American healthy controls as compared to Caucasian American healthy controls. On the other hand, adjusting for age at baseline, sex, disease duration, and history of optic neuritis in patients with multiple sclerosis, rates of p-RNFL (−1.1%/year versus −0.8%/year; P = 0.019), GCIP (−0.8%/year versus −0.4%/year; P = 0.009), and average macular thickness thinning (−0.3%/year versus −0.2%/year; P = 0.003) were all faster in African Americans as compared to Caucasian Americans. Relative to Caucasian Americans, African Americans with multiple sclerosis also exhibited borderline faster rates of ONL atrophy (−0.3%/year versus −0.2%/year; P = 0.077).

Table 5

Comparisons of retinal layer atrophy (percentage change/year)a

Retinal layer thickness atrophy (percentage of change/year)
African AmericansCaucasian AmericansAfrican Americans versus Caucasian Americans P-value
%/year95% CI%/year95% CIModel 1bModel 2c
Healthy controlsn = 17n = 33
p-RNFL−0.42(−0.95 to 0.11)−0.40(−0.67 to −0.13)0.648NA
GCIP−0.37(−0.72 to −0.02)−0.13(−0.35 to 0.08)0.272NA
INL−0.34(−0.62 to −0.07)−0.20(−0.36 to −0.03)0.383NA
ONL−0.18(−0.45 to 0.09)−0.17(−0.31 to −0.03)0.927NA
AMT−0.14(−0.34 to 0.06)−0.08(−0.20 to 0.04)0.632NA
Multiple sclerosisn = 116n = 116
p-RNFL−1.10(−1.31 to −0.89)−0.74(−0.93 to −0.56)0.0190.018
GCIP−0.77(−0.95 to −0.60)−0.40(−0.56 to −0.24)0.0090.009
INL−0.29(−0.36 to −0.22)−0.32(−0.38 to −0.26)0.4440.439
ONL−0.27(−0.35 to −0.18)−0.16(−0.23 to −0.08)0.0760.076
AMT−0.30(−0.37 to −0.23)−0.15(−0.21 to −0.09)0.0030.003
Retinal layer thickness atrophy (percentage of change/year)
African AmericansCaucasian AmericansAfrican Americans versus Caucasian Americans P-value
%/year95% CI%/year95% CIModel 1bModel 2c
Healthy controlsn = 17n = 33
p-RNFL−0.42(−0.95 to 0.11)−0.40(−0.67 to −0.13)0.648NA
GCIP−0.37(−0.72 to −0.02)−0.13(−0.35 to 0.08)0.272NA
INL−0.34(−0.62 to −0.07)−0.20(−0.36 to −0.03)0.383NA
ONL−0.18(−0.45 to 0.09)−0.17(−0.31 to −0.03)0.927NA
AMT−0.14(−0.34 to 0.06)−0.08(−0.20 to 0.04)0.632NA
Multiple sclerosisn = 116n = 116
p-RNFL−1.10(−1.31 to −0.89)−0.74(−0.93 to −0.56)0.0190.018
GCIP−0.77(−0.95 to −0.60)−0.40(−0.56 to −0.24)0.0090.009
INL−0.29(−0.36 to −0.22)−0.32(−0.38 to −0.26)0.4440.439
ONL−0.27(−0.35 to −0.18)−0.16(−0.23 to −0.08)0.0760.076
AMT−0.30(−0.37 to −0.23)−0.15(−0.21 to −0.09)0.0030.003

aPercentage of change derived by the natural logarithm of each variable obtained in Model 1.

bModels adjusted for sex and baseline age.

cModels adjusted for sex, age at baseline, disease duration and history optic neuritis.

AMT = average macular thickness; NA = not applicable. Bold values indicate statistical significance (P < 0.05).

Table 5

Comparisons of retinal layer atrophy (percentage change/year)a

Retinal layer thickness atrophy (percentage of change/year)
African AmericansCaucasian AmericansAfrican Americans versus Caucasian Americans P-value
%/year95% CI%/year95% CIModel 1bModel 2c
Healthy controlsn = 17n = 33
p-RNFL−0.42(−0.95 to 0.11)−0.40(−0.67 to −0.13)0.648NA
GCIP−0.37(−0.72 to −0.02)−0.13(−0.35 to 0.08)0.272NA
INL−0.34(−0.62 to −0.07)−0.20(−0.36 to −0.03)0.383NA
ONL−0.18(−0.45 to 0.09)−0.17(−0.31 to −0.03)0.927NA
AMT−0.14(−0.34 to 0.06)−0.08(−0.20 to 0.04)0.632NA
Multiple sclerosisn = 116n = 116
p-RNFL−1.10(−1.31 to −0.89)−0.74(−0.93 to −0.56)0.0190.018
GCIP−0.77(−0.95 to −0.60)−0.40(−0.56 to −0.24)0.0090.009
INL−0.29(−0.36 to −0.22)−0.32(−0.38 to −0.26)0.4440.439
ONL−0.27(−0.35 to −0.18)−0.16(−0.23 to −0.08)0.0760.076
AMT−0.30(−0.37 to −0.23)−0.15(−0.21 to −0.09)0.0030.003
Retinal layer thickness atrophy (percentage of change/year)
African AmericansCaucasian AmericansAfrican Americans versus Caucasian Americans P-value
%/year95% CI%/year95% CIModel 1bModel 2c
Healthy controlsn = 17n = 33
p-RNFL−0.42(−0.95 to 0.11)−0.40(−0.67 to −0.13)0.648NA
GCIP−0.37(−0.72 to −0.02)−0.13(−0.35 to 0.08)0.272NA
INL−0.34(−0.62 to −0.07)−0.20(−0.36 to −0.03)0.383NA
ONL−0.18(−0.45 to 0.09)−0.17(−0.31 to −0.03)0.927NA
AMT−0.14(−0.34 to 0.06)−0.08(−0.20 to 0.04)0.632NA
Multiple sclerosisn = 116n = 116
p-RNFL−1.10(−1.31 to −0.89)−0.74(−0.93 to −0.56)0.0190.018
GCIP−0.77(−0.95 to −0.60)−0.40(−0.56 to −0.24)0.0090.009
INL−0.29(−0.36 to −0.22)−0.32(−0.38 to −0.26)0.4440.439
ONL−0.27(−0.35 to −0.18)−0.16(−0.23 to −0.08)0.0760.076
AMT−0.30(−0.37 to −0.23)−0.15(−0.21 to −0.09)0.0030.003

aPercentage of change derived by the natural logarithm of each variable obtained in Model 1.

bModels adjusted for sex and baseline age.

cModels adjusted for sex, age at baseline, disease duration and history optic neuritis.

AMT = average macular thickness; NA = not applicable. Bold values indicate statistical significance (P < 0.05).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close